CXCR4 and infection: A neutralizing TNF-α antibody, infliximab (4 μg/ml, Sigma), was then used to treat MKN45 and HGC27 cells after an infection by 26695, and the induction of CXCR4 was inhibited significantly (P < 0.01, respectively, Figure 3A, B).